With two attempts to merge with other companies having collapsed, Vincerx Pharma has been left with no choice but to start winding down. The antibody-drug conjugate biotech had been in the process of making a last-ditch push to merge with computing infrastructure company QumulusAI. The privately owned AI-focused company would have used the merger to join the Nasdaq via Vincerx’s listing. But Vincerx revealed in a post-market release Tuesday that it has now terminated the nonbinding letter of intent regarding the merger.
Read the full article: Vincerx’s Final Merger Attempt Collapses, Leaving ADC Biotech to Wind Down //
Source: https://www.fiercebiotech.com/biotech/vincerxs-final-merger-attempt-collapses-leaving-adc-biotech-wind-down